Authors:
Lin, FYC
Ho, VA
Khiem, HB
Trach, DD
Bay, PV
Thanh, TC
Kossaczka, Z
Bryla, DA
Shiloach, J
Robbins, JB
Schneerson, R
Szu, SC
Lanh, MN
Hunt, S
Trinh, L
Kaufman, JB
Citation: Fyc. Lin et al., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children, N ENG J MED, 344(17), 2001, pp. 1263-1269
Authors:
Passwell, JH
Harlev, E
Ashkenazi, S
Chu, CY
Miron, D
Ramon, R
Farzan, N
Shiloach, J
Bryla, DA
Majadly, F
Roberson, R
Robbins, JB
Schneerson, R
Citation: Jh. Passwell et al., Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel, INFEC IMMUN, 69(3), 2001, pp. 1351-1357
Authors:
Taranger, J
Trollfors, B
Lagergard, T
Sundh, V
Bryla, DA
Schneerson, R
Robbins, JB
Citation: J. Taranger et al., Correlation between pertussis toxin IgG antibodies in postvaccination seraand subsequent protection against pertussis, J INFEC DIS, 181(3), 2000, pp. 1010-1013
Authors:
Pavliakova, D
Moncrief, JS
Lyerly, DM
Schiffman, G
Bryla, DA
Robbins, JB
Schneerson, R
Citation: D. Pavliakova et al., Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice, INFEC IMMUN, 68(4), 2000, pp. 2161-2166
Authors:
Konadu, EY
Lin, FYC
Ho, VA
Thuy, NTT
Bay, PV
Thanh, TC
Khiem, HB
Trach, DD
Karpas, AB
Li, J
Bryla, DA
Robbins, JB
Szu, SC
Citation: Ey. Konadu et al., Phase 1 and phase 2 studies of Salmonella enterica serovar Paratyphi A O-specific polysaccharide-tetanus toroid conjugates in adults, teenagers, and 2-to 4-year-old children in Vietnam, INFEC IMMUN, 68(3), 2000, pp. 1529-1534
Authors:
Trollfors, B
Taranger, J
Lagergard, T
Sundh, V
Bryla, DA
Schneerson, R
Robbins, JB
Citation: B. Trollfors et al., Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis, CLIN INF D, 28(3), 1999, pp. 552-559
Authors:
Ashkenazi, S
Passwell, JH
Harlev, E
Miron, D
Dagan, R
Farzan, N
Ramon, R
Majadly, F
Bryla, DA
Karpas, AB
Robbins, JB
Schneerson, R
Citation: S. Ashkenazi et al., Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children, J INFEC DIS, 179(6), 1999, pp. 1565-1568
Authors:
Kossaczka, Z
Lin, FYC
Ho, VA
Thuy, NTT
Van Bay, P
Thanh, TC
Khiem, HB
Trach, DD
Karpas, A
Hunt, S
Bryla, DA
Schneerson, R
Robbins, JB
Szu, SC
Citation: Z. Kossaczka et al., Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam, INFEC IMMUN, 67(11), 1999, pp. 5806-5810
Authors:
Pavliakova, D
Chu, CY
Bystricky, S
Tolson, NW
Shiloach, J
Kaufman, JB
Bryla, DA
Robbins, JB
Schneerson, R
Citation: D. Pavliakova et al., Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice, INFEC IMMUN, 67(10), 1999, pp. 5526-5529